10/14/2026
For children and families facing neuroblastoma, new research can bring new possibilities and new hope.
ICRF and Shir for Life are partnering to fund new research into neuroblastoma, a rare and often difficult-to-treat childhood cancer.
The three-year, $180,000 grant will support Prof. Ravid Straussman of the Weizmann Institute of Science as he investigates how bacteria within neuroblastoma tumors may influence tumor development, immune activity, and response to treatment.
Through this partnership, ICRF and Shir for Life are supporting research that could lead to new treatment options and greater hope for children and families facing neuroblastoma.
Read the full announcement here: https://www.icrfonline.org/news/israel-cancer-research-fund-and-shir-for-life-partner-to-fund-research-on-the-tumor-microbiome-in-neuroblastoma/